---
$id: https://graph.org.ai/products/commodity/51202602
$type: Product
source: UNSPSC
code: "51202602"
title: "Anisperimus"
class: "51202600"
classTitle: "Immunosupressant imides"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Anisperimus

**UNSPSC Code**: 51202602
**Class**: [Immunosupressant imides](Immunosupressant imides.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant with the molecular formula C18H39N7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0514P112G. The term ANISPERIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, list 44). As of Q4 2014, ANISPERIMUS remains US FDA's Preferred Term for this commodity. Anisperimus bears US NLM identifiers UMLS ID C2698118 and NCI Concept Code C77593. Most nations, for tariff and trade purposes, schedule Anisperimus under HS 29252900 and SITC 51482 (for the most current information on WCO designations on anisperimus and salts thereof, please see Committee proceedings HSC/53, NC2004B1b Ann. O/6, 2014). SMILES: C[C@H](CCNCCCCNC(=O)OCC(=O)NCCCCCCNC(=N)N)N.

